Natco Pharma Limited has announced the completion of an inspection by the United States Food and Drug Administration (USFDA) for its Pharma Division located in Kothur Hyderabad, India, which was conducted from 9th October, 2023 to 18th October, 2023.

At the end of the inspection, the facility received 8 observations. The company is confident of addressing all the observations within the stipulated time and working with USFDA to close them at the earliest.